John Knight, MD
Endocrinology, Diabetes & Metabolism · Jackson, MSNPI 1386008928
Payments from drug & device makers
Across 482 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$1K
- Corcept Therapeutics$739
- Bayer$694
- Novartis$670
- Abbott$646
- plus $4K from 36 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 56 | $1,210 |
| Lilly USA, LLC | 66 | $1,054 |
| Corcept Therapeutics | 25 | $739 |
| Bayer | 39 | $694 |
| Novartis | 41 | $670 |
| Abbott | 39 | $646 |
| Amgen(2 entities) | 34 | $533 |
| Dexcom, Inc. | 18 | $398 |
| Sanofi-aventis U.S. LLC | 13 | $233 |
| Insulet Corporation | 7 | $211 |
| Merck | 11 | $204 |
| Tandem Diabetes Care, Inc. | 13 | $185 |
| Medtronic | 8 | $171 |
| AstraZeneca(2 entities) | 10 | $149 |
| Esperion Therapeutics, Inc. | 8 | $136 |
| Recordati_rare_diseases_inc. | 7 | $132 |
| BETA Bionics, Inc. | 7 | $126 |
| Pfizer | 8 | $122 |
| Abiomed | 4 | $121 |
| Kyowa Kirin, Inc. | 6 | $111 |
| AbbVie | 6 | $104 |
| Boehringer Ingelheim | 7 | $101 |
| Neurocrine Biosciences, Inc. | 5 | $97 |
| Ascendis Pharma Endocrinology Inc | 5 | $89 |
| Lifescan, Inc. | 6 | $87 |
| Amryt Pharma Holdings Ltd | 3 | $76 |
| Sequel Med Tech, LLC | 4 | $74 |
| Xeris Pharmaceuticals, Inc. | 3 | $74 |
| Antares Pharma, Inc. | 3 | $67 |
| Astellas Pharma US Inc | 3 | $53 |
| IBSA Pharma Inc. | 3 | $44 |
| Amneal Pharmaceuticals LLC | 2 | $43 |
| BD | 2 | $32 |
| Acella Pharmaceuticals, LLC | 2 | $31 |
| Averitas Pharma Inc. | 1 | $29 |
| EUSA Pharma (US) LLC | 1 | $21 |
| Acerus Pharmaceuticals Corporation | 1 | $20 |
| Chiesi USA, Inc. | 1 | $19 |
| Embecta Corp. | 1 | $18 |
| GSK | 1 | $17 |
| Tolmar, Inc. | 1 | $17 |
| Ascensia Diabetes Care US Inc. | 1 | $14 |
How this compares
$8,970 in reported general payments places this provider in the 60th percentile of 48 endocrinology, diabetes & metabolism providers in Mississippi.
See all endocrinology, diabetes & metabolism providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Jackson
- Honey EastJackson$904K
- Eric DyessJackson$885K
- Ben SealeJackson$623K
- Amanda SchieferJackson$204K
- John SistrunkJackson$133K
- Vishnu GarlaJackson$88K
- Raymond GrenfellJackson$16K
- Vanessa SandiferJackson$14K
- Jana PhillipsJackson$8K
- Robert EvansJackson$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.